![Erik Domines](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Erik Domines worked as the General Counsel at Recipharm AB from 2014 to 2018 and at Xbrane Biopharma AB from 2021 to 2023.
He completed his undergraduate degree at the University of Stockholm.
Eerdere bekende functies van Erik Domines
| Bedrijven | Functie | Einde |
|---|---|---|
| XBRANE BIOPHARMA AB | Algemeen Adviseur | 01-07-2023 |
| RECIPHARM AB (PUBL) | Algemeen Adviseur | 31-12-2018 |
Opleiding van Erik Domines
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
15
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Recipharm AB
 Recipharm AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical contract development and manufacturing organization | Health Technology |
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xbrane Biopharma AB
 Xbrane Biopharma AB Pharmaceuticals: MajorHealth Technology Develops and manufactures biosimilars for s eye diseases | Health Technology |
